Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Announces Third Quarter Fiscal Year 2008 Financial Results
August 22nd, 2008
Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced financial results for the three and nine months ended June 30, 2008. The Company reported a net loss of $580,000, or $0.02 per share, compared to a loss of $509,000, or $0.02 per share, for the three months ended June 30, 2007, an increase of 14%. For the nine months ended June 30, 2008, the Company reported a net loss of $1,918,000, or $0.06 per share, compared to a loss of $2,002,000, or $0.07 per share, for the nine months ended June 30, 2007. "With the completion of our recent financing, we are now in position to initiate mouse and primate studies of AEOL 10150 as a protective agent against...
Source: Health Business Week (2008-08-22)
|
